Evaxion A/S (EVAX) Earnings Call Transcripts

23 earnings calls from March 2022 to August 20, 2026

NasdaqCM US Health Care Biotechnology

About Evaxion A/S

Evaxion A/S (EVAX) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 23 calls on record spanning March 22, 2022 to August 20, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 23 Evaxion A/S earnings call transcripts on record, spanning March 22, 2022 to August 20, 2026. Based on this history, Evaxion A/S reports quarterly. The most recent call on file is dated August 20, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
EVAX
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
23
First call
March 22, 2022
Most recent
August 20, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 20, 2026 Read transcript →
Q1 FY2026 May 7, 2026 Read transcript →
Earnings Calls Mar 6, 2026 Read transcript →
Q3 FY2025 Nov 6, 2025 Read transcript →
Special Calls Oct 22, 2025 Read transcript →
Special Calls Sep 25, 2025 Read transcript →
Q2 FY2025 Aug 14, 2025 Read transcript →
Q1 FY2025 May 27, 2025 Read transcript →
Earnings Calls Apr 1, 2025 Read transcript →
Special Calls Feb 19, 2025 Read transcript →
Q3 FY2024 Oct 31, 2024 Read transcript →
Special Calls Sep 27, 2024 Read transcript →
Q2 FY2024 Aug 14, 2024 Read transcript →
Earnings Calls Apr 2, 2024 Read transcript →
Special Calls Mar 19, 2024 Read transcript →
Special Calls Nov 8, 2023 Read transcript →
Q2 FY2023 Aug 22, 2023 Read transcript →
Special Calls May 25, 2023 Read transcript →
Q4 FY2022 Apr 27, 2023 Read transcript →
Q2 FY2022 Aug 10, 2022 Read transcript →
Q1 FY2022 May 11, 2022 Read transcript →
Special Calls Apr 12, 2022 Read transcript →
Q4 FY2021 Mar 22, 2022 Read transcript →